Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for chemoradiotherapy.

Yasumasa Nishimura1

  • 1Department of Radiology, Kinki University School of Medicine, Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan. ynishi@med.kindai.ac.jp

International Journal of Clinical Oncology
|December 24, 2004
PubMed
Summary

Combining chemotherapy (CT) and radiotherapy (RT) enhances cancer treatment. Concurrent chemoradiotherapy (CRT) improves local control and survival, despite increased acute toxicity, offering a therapeutic benefit.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Definitive IMRT alone with reduced prophylactic nodal irradiation for Early-Stage Oropharyngeal Cancer: JCOG1208.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same author

Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L.

JTO clinical and research reports·2025
Same author

Neoadjuvant Concurrent Chemo-Immuno-Radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage III N2 NSCLC: Primary Results From the SQUAT Trial (WJOG 12119L).

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2025
Same author

Incidence and risk factors associated with the development of hypothyroidism after postoperative chemoradiotherapy for head and neck cancer patients with high-risk features: Supplementary analysis of JCOG1008.

Oral oncology·2024
Same author

Stereotactic body radiation therapy for multiple lung cancers in a patient with six primary cancers: a case report.

Journal of medical case reports·2024
Same author

Cone-beam computed tomography-guided online adaptive radiotherapy for pharyngeal cancer with whole neck irradiation: dose-volume histogram analysis between adapted and scheduled plans.

Journal of radiation research·2024

Area of Science:

  • Oncology
  • Radiation Oncology
  • Medical Physics

Background:

  • Combining chemotherapy (CT) and radiotherapy (RT) aims for spatial cooperation and enhanced radiation effects.
  • CT can eradicate subclinical metastases, while RT treats the primary tumor, requiring differing toxicities for effective dosages.

Purpose of the Study:

  • To explore the mechanisms of CT-RT interactions for enhancing radiotherapy efficacy.
  • To evaluate the impact of CT-RT sequencing on treatment outcomes.

Main Methods:

  • Review of CT-RT interaction mechanisms, including DNA damage, repair inhibition, cell cycle modulation, hypoxia targeting, and repopulation inhibition.
  • Analysis of clinical trial data and meta-analyses on induction CT followed by RT versus concurrent chemoradiotherapy (CRT).

Main Results:

  • Induction CT followed by RT showed disappointing results in improving local control.
  • Concurrent chemoradiotherapy (CRT) demonstrated improved local control and survival rates in clinical trials.
  • While acute toxicities increased with CRT, late toxicities were not significantly elevated in most studies.

Conclusions:

  • Concurrent chemoradiotherapy (CRT) offers a therapeutic benefit by improving tumor response more than normal tissue damage.
  • The sequence of CT and RT is critical, with concurrent administration being superior to induction CT followed by RT.

Related Experiment Videos